Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, 38152, United States
NCT Number: NCT04234529
AMATEA™ is a patented dietary supplement consisting of a unique blend of caffeine and polyphenol antioxidants; standardized at 20% caffeine, 30% chlorogenic acids (similar to green coffee). In-house evaluations and anecdotal findings related to AMATEA have noted sustained energy without the typical "crash" and/or "jitters" experienced by some with caffeine ingestion alone.
The aim of the present study is to compare the effects of AMATEA and caffeine alone on various measures of cognitive performance, mood, and gaming performance in men and women who regularly engage in gaming activity. The investigators hypothesize that both AMATEA and caffeine will improve outcome measures more than placebo, with greater improvement noted for the AMATEA condition due to the addition of the chlorogenic acid.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Memphis, Tennessee, 38152, United States
The activity of "gaming" is increasing in popularity each year, with millions of young adults engaged in regular play. This has fueled the rise in nutrition and dietary supplementation strategies to aid gaming performance. Since caffeine has been widely used for purposes of improving athletic performance with both relatively low and high dosages, and more recently as a potential aid for "mind" games such as chess at a dosage of 400mg, this has been the nutrient of focus for many gamers. Other multi-component products are making their way to the market.
Active gamers claim to ingest such products regularly throughout their gameplay, which can span from 4-12 hours per session for regular gamers. AMATEA™ is a patented dietary supplement consisting of a unique blend of caffeine and polyphenol antioxidants; standardized at 20% caffeine, 30% chlorogenic acids (similar to green coffee). The product is also Generally Recognized as Safe (GRAS) and USDA organic.
While caffeine has been well-investigated for its performance boosting effects, chlorogenic acid has been reported to offer many potential health benefits. Specifically, it has been reported to improve select cognitive measures following regular intake, which may translate into more efficient performance with complex tasks-such as those involved with gaming.
In-house evaluations and anecdotal findings related to AMATEA have noted sustained energy without the typical "crash" and/or "jitters" experienced by some with caffeine ingestion alone. While caffeine can prove beneficial to many, some users experience "crashing" 2-3 hours post ingestion, while others feel too "wired" following use and may experience difficulty concentrating. AMATEA contains a relatively low concentration of caffeine per capsule (150mg) in an attempt to avoid such problems, while also containing chlorogenic acid. This may aid gamers who need to maintain fine motor skills and those who need to concentrate on complex activities for several hours continuously.
The aim of the present study is to compare the effects of AMATEA and caffeine alone on various measures of cognitive performance, mood, and gaming performance in men and women who regularly engage in gaming activity. The investigators hypothesize that both AMATEA and caffeine will improve outcome measures more than placebo, with greater improvement noted for the AMATEA condition due to the addition of the chlorogenic acid.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AMATEA™ is a patented dietary supplement consisting of a unique blend of caffeine and polyphenol antioxidants; standardized at 20% caffeine, 30% chlorogenic acids (similar to green coffee).
Total of 1.35g of AMATEA containing 270mg of caffeine.
1.08g of microcellulose and 270mg of caffeine.
1.35g of microcellulose
Time frame: During 4 hours of gaming following AMATEA ingestion
We will determine the change in the Fortnite gaming metrics report following 4 hours of play when taking AMATEA versus placebo or caffeine
Time frame: During 4 hours of gaming following caffeine ingestion
We will determine the change in the Fortnite gaming metrics report following 4 hours of play when taking caffeine versus placebo or AMATEA
Time frame: During 4 hours of gaming following placebo ingestion
We will determine the change in the Fortnite gaming metrics report following 4 hours of play when taking placebo versus AMATEA or caffeine
Time frame: Prior to and during the 6 hour period following AMATEA ingestion
We will determine the change in daily mental performance assessed via AX-CPT when taking AMATEA versus caffeine or placebo
Time frame: Prior to and during the 6 hour period following caffeine ingestion
We will determine the change in daily mental performance assessed via AX-CPT when taking caffeine versus caffeine or AMATEA
Time frame: Prior to and during the 6 hour period following placebo ingestion
We will determine the change in daily mental performance assessed via AX-CPT when taking placebo versus caffeine or AMATEA
Time frame: Prior to and during the 6 hour period following AMATEA ingestion
We will determine the change in daily blood cortisol when taking AMATEA versus caffeine or placebo
Time frame: Prior to and during the 6 hour period following caffeine ingestion
We will determine the change in daily blood cortisol when taking caffeine versus AMATEA or placebo
Time frame: Prior to and during the 6 hour period following placebo ingestion
We will determine the change in daily blood cortisol when taking placebo versus AMATEA or caffeine
Time frame: Prior to and during the 6 hour period following AMATEA ingestion
We will determine the change in digital symbol substitution when taking AMATEA versus caffeine or placebo
Time frame: Prior to and during the 6 hour period following caffeine ingestion
We will determine the change in digital symbol substitution when taking caffeine versus AMATEA or placebo
Time frame: Prior to and during the 6 hour period following placebo ingestion
We will determine the change in digital symbol substitution when taking placebo versus AMATEA or caffeine
Time frame: Prior to and during the 6 hour period following AMATEA ingestion
We will determine the change in reaction time when taking AMATEA versus caffeine or placebo
Time frame: Prior to and during the 6 hour period following caffeine ingestion
We will determine the change in reaction time when taking caffeine versus AMATEA or placebo
Time frame: Prior to and during the 6 hour period following placebo ingestion
We will determine the change in reaction time when taking placebo versus AMATEA or caffeine
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in heart rate each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in blood pressure each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in rate pressure product each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in digital symbol substitution test each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in Brunel Mood Score (Brums-32) using a scale 0 (Not at all) to 4 (Extremely) with higher scores indicating stronger feelings each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in subjective mood using a visual analog schedule running from None to Extreme, where values nearer extreme indicate stronger feelings each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in reaction time each hour after ingestion
Time frame: Prior to and during the 6 hour period following supplement/placebo ingestion
Change in blood cortisol from baseline every 2 hours after ingestion for 4 hours
University of Memphis
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details